Udonitrectag

N/A

Report date: 2024/12/18 10:01:46
NME

Base Information

Drug NameUdonitrectag
Drug Alias NameNegermin lysine saltudonitrectag lysineREC-0559MT-8REC 0/0559
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAutophagy inhibitorsApoptosis inhibitorsNerve growth factor receptors agonists
TargetsNerve growth factor receptors
Therapy Area/IndicationsNeurotrophic Keratitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItalyHungary +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMimetech SRL
China Registration ClassN/A

Develop Information

Active CompaniesRecordati Rare Diseases Inc
Inactive CompaniesN/A
Active IndicationsNeurotrophic Keratitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A